Filter
67
Text search:
Trichiasis
due
to
trachoma
Featured
Recommendations
8
New Publications
15
Language
Document type
No document type
25
Studies & Reports
23
Strategic & Response Plan
10
Manuals
5
Guidelines
2
Fact sheets
2
Countries / Regions
Global
8
Kenya
3
Africa
3
Ethiopia
2
Nepal
2
Burkina Faso
1
Saudi Arabia
1
Somalia
1
Pakistan
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Egypt
1
Syria
1
Malawi
1
Mozambique
1
Sudan
1
Libya
1
Myanmar / Burma
1
Yemen
1
Latin America and the Carribbean
1
Palestine
1
Djibouti
1
Qatar
1
Iran
1
Authors & Publishers
Publication Years
Category
Countries
12
Clinical Guidelines
10
Public Health
5
Key Resources
4
Capacity Building
1
Toolboxes
NTDs
36
Disability
5
Ebola & Marburg
1
Caregiver
1
Planetary Health
1
NCDs
1
Malaria
1
A key component of elimination is to reduce the number
of unmanaged trachomatous trichiasis cases to less than
1 per 1,000 population in affected
...
Trichiasis is when the eyelashes turn inward towards the eye and scratch the eye. All the lashes may turn in and rub, or it may be just a few eyelashes. The person with trichiasis usually feels pain
...
Wiping out Trachoma from Nepal – How Nepal eliminated trachoma as a public health problem
WHO - 2018
Surveys are needed to guide trachoma control efforts in Mozambique, with WHO guidelines for intervention based on the prevalence of trachomatous inflammation–follicular (TF) in children aged 1–9
...
These standard operating procedures are intended to be used when a Member State wishes to request validation of national elimination of trachoma as
...
The World Health Organization (WHO) endorses the use of population-based prevalence surveys for estimating the prevalence of trachoma. In general, the prevalence of TF in children aged 1–9 years and the prevalence of TT in adults aged ≥ 15 years
...
The World Health Organization (WHO) endorses the use of population-based prevalence surveys for estimating the prevalence of trachoma. In general, the prevalence of TF in children aged 1–9 years and the prevalence of TT in adults aged ≥ 15 years
...
The Fifty-first World Health Assembly adopted resolution WHA51.11 in 1998, which targets the
global elimination of trachoma as a public health problem by 2020 (1). The strategy recommended
to achi
...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads
...
The second edition of the Women and Trachoma: Achieving Gender Equity in the Implementation of SAFE manual provides an updated resource for realistically increasing, improving, and supporting gender representation within
...
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and di
...
Weekly epidemiological record 18 July 2025
This report summarizes application of the SAFE strategy against trachoma during 2024. It includes estimates of the global population at risk of trachoma b
...
COMMUNITY EYE HEALTH JOURNAL | VOLUME 33 | NUMBER 110 | 2020
Trichiasis surgery for trachoma
recommended
3rd edition
ICTC’s 2022-2030 strategic plan spans the critical period running to the end of 2030, the year by which we are striving to achieve the elimination of tr
...
Trachoma is an eye infection that for thousands of years caused many people to go blind across all continents. As the result of development and targeted interventions,
...
Weekly Epidemiological Record. This report summarizes application of the SAFE strategy against trachoma during 2023. It includes estimates of the global population at risk of trachoma blindness base
...
This guide has been written for managers of national and district trachoma control programmes. It sets out, step-by-step, what is needed to assess the magnitude and extent of the
...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma
...
